AI-generated summary
The authors retrospectively reviewed 69 patients with solid tumors who received 5-fluorouracil chemotherapy and a structured oral care strategy that included photobiomodulation. They report that two photobiomodulation sessions were associated with reduced onset, severity and duration of oral mucositis, with stronger associations for some regimens. The authors call for prospective multicenter studies to validate these findings.
- Participants
- 69
- Who or what was studied
- Patients with solid tumors receiving 5-fluorouracil-based chemotherapy at a single center, treated between 2020 and 2022
- Limits stated in the abstract
- The study is a single-center retrospective cohort analysis, and the abstract itself calls for prospective multicenter studies to validate the findings.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Oral mucositis, GRADE. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.